|
|
|
Volumn 23, Issue 3 SUPPL. 7, 1996, Pages 19-27
|
|
The role of ifosfamide in the treatment of testicular and urothelial malignancies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLCYSTEINE;
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CALCITRIOL;
CARBOPLATIN;
CISPLATIN;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
GALLIUM NITRATE;
IFOSFAMIDE;
METHOTREXATE;
PACLITAXEL;
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
VINBLASTINE;
VINCA ALKALOID;
BLADDER CANCER;
BONE MARROW TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DRUG MEGADOSE;
GERM CELL TUMOR;
GRANULOCYTOPENIA;
HUMAN;
HYPOCALCEMIA;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NEPHROTOXICITY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
TESTIS CANCER;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, TRANSITIONAL CELL;
CLINICAL TRIALS;
GERMINOMA;
HUMANS;
IFOSFAMIDE;
MALE;
SALVAGE THERAPY;
TESTICULAR NEOPLASMS;
URINARY BLADDER NEOPLASMS;
|
|
EID: 0029737965
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (0)
|
